Pipamperone



Indications and Reactions:

Role Indications Reactions
Primary
Schizophrenia, Disorganised Type 100.0%
Swelling Face 50.0%
Weight Increased 50.0%
Secondary
Product Used For Unknown Indication 41.0%
Drug Abuse 32.0%
Drug Use For Unknown Indication 5.0%
Schizophrenia 3.9%
Bipolar I Disorder 3.5%
Premedication 2.5%
Agitation 2.2%
Psychotic Disorder 1.5%
Bipolar Disorder 1.4%
Suicide Attempt 1.0%
Anaesthesia 0.8%
Overdose 0.8%
Hypertension 0.7%
Schizophrenia, Paranoid Type 0.7%
Cerebrovascular Accident 0.6%
Neuroleptic Malignant Syndrome 0.6%
Depression 0.4%
Epilepsy 0.4%
Schizoaffective Disorder 0.4%
Sleep Disorder 0.4%
Suicide Attempt 23.6%
Neuroleptic Malignant Syndrome 12.7%
Subileus 9.1%
Body Temperature Decreased 5.5%
Hypothermia 5.5%
Tachycardia 5.5%
Confusional State 3.6%
Neonatal Tachypnoea 3.6%
Pneumonia 3.6%
Psychotic Disorder 3.6%
Surgery 3.6%
Tremor 3.6%
Vomiting 3.6%
Adverse Drug Reaction 1.8%
Blood Creatine Phosphokinase Increased 1.8%
Coma 1.8%
Delusion Of Reference 1.8%
Drug Abuser 1.8%
Dystonia 1.8%
Heart Rate Increased 1.8%
Concomitant
Product Used For Unknown Indication 26.3%
Major Depression 8.6%
Hypertension 7.6%
Schizophrenia 7.2%
Drug Use For Unknown Indication 6.9%
Depression 6.3%
Prophylaxis 5.6%
Atrial Fibrillation 4.6%
Sleep Disorder 4.6%
Anxiety 3.3%
Pain 3.0%
Dementia 2.6%
Bipolar I Disorder 2.3%
Dementia Alzheimer's Type 2.3%
Psychotic Disorder 2.0%
Sedation 1.6%
Anaesthesia 1.3%
Histiocytosis Haematophagic 1.3%
Hypercholesterolaemia 1.3%
Peritoneal Dialysis 1.3%
Tic 12.5%
Bradyarrhythmia 7.1%
Death 7.1%
Renal Failure Acute 7.1%
Skin Exfoliation 7.1%
Syncope 7.1%
Breast Cancer 5.4%
Arrhythmia 3.6%
Body Temperature Increased 3.6%
Erysipelas 3.6%
Haemoglobin Decreased 3.6%
Insomnia 3.6%
Lipase Increased 3.6%
Periodontitis 3.6%
Salivary Hypersecretion 3.6%
Sepsis 3.6%
Suicidal Ideation 3.6%
Suicide Attempt 3.6%
Swollen Tongue 3.6%
Tachycardia 3.6%
Interacting
Drug Use For Unknown Indication 77.8%
Anxiety 11.1%
Cerebrovascular Accident Prophylaxis 11.1%
Drug Interaction 50.0%
Myopathy 50.0%